Assyro AI

Orange Book product · Generic (ANDA)

PAMIDRONATE DISODIUM

PAMIDRONATE DISODIUM

Generic (ANDA)ANDA 078520TE AP2RX MYLAN LABS LTD
View PAMIDRONATE DISODIUM familyOpen on FDA Orange Book

At a glance

Oct 31, 2008

Approved

Generic (ANDA)

Application

AP2

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 31, 2008

    17 yr 11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

PAMIDRONATE DISODIUM

Strength

30MG/10ML (3MG/ML)

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP2

Application

ANDA 078520

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of PAMIDRONATE DISODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo